Growth differentiation factor 15 level changes in the early and late periods after radiofrequency and pulsed field catheter ablation of atrial fibrillation
Frontiers in Cardiovascular Medicine · 05.08.2026 · 13
DOI: 10.3389/fcvm.2026.1798578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 05.08.2026. Verfasst von Barbora Steklá und 6 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Medicine-Department of Cardiovascular Medicine of the 1st Faculty of Medicine, Charles University and General University Hospital i…. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
GDF-15 (growth differentiation factor 15) is a protein from the transforming growth factor β (TGF- β ) cytokine family. In patients with atrial fibrillation (AF), it is a potent marker of bleeding adverse events in anticoagulated patients and a predictor of overall mortality. However, its level is affected by various conditions, including radiofrequency catheter ablation (RFCA). The study aimed to describe the dynamics of GDF-15 following a novel AF treatment approach, pulsed field ablation (PFA).
Methods
This prospective observational study enrolled 50 patients [median (IQR) age 63 (53; 71) years, 62% males] undergoing PFA and compared them with 50 patients [65 (57; 69) years, 64% males] post-RFCA.
Results
In the PFA group, 30 (60%) patients had paroxysmal AF, compared with 20 (40%) patients in the RFCA group. The median (IQR) GDF-15 level at baseline was 943 (733; 1,148) ng/L. The median value recorded 24 h after PFA was 1,363 (901; 1,867) ng/L. No significant difference in values was observed between patients treated with RFCA and those treated with PFA. However, when comparing GDF-15 values in paroxysmal AF separately, significantly higher post-procedural GDF-15 levels (immediately post-ablation and in 24 h after procedure) were observed after PFA than RFCA: 963 (672; 1,266) vs. 630 (506; 804) ng/L with p < 0.001 and 1,363 (901; 1,960) vs. 843 (710; 1,195) ng/L, p < 0.01, respectively. No correlation was found between GDF-15 levels and procedural data.
Conclusion
GDF-15 levels are significantly affected by catheter ablation of AF, regardless of the ablation technology used.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Department of Medicine-Department of Cardiovascular Medicine of the 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
- Institute of Medical Biochemistry and Laboratory Diagnostics of the 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
Zitieren
APA
Steklá, B., Pelinková, K., Benáková, H., Šimek, J., Dusík, M., Linhart, A., & Havránek, Š. (2026). Growth differentiation factor 15 level changes in the early and late periods after radiofrequency and pulsed field catheter ablation of atrial fibrillation. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1798578
Vancouver
Steklá B, Pelinková K, Benáková H, Šimek J, Dusík M, Linhart A, et al. Growth differentiation factor 15 level changes in the early and late periods after radiofrequency and pulsed field catheter ablation of atrial fibrillation. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1798578
BibTeX
@article{Stekl2026,
author = {Steklá, Barbora and Pelinková, Květa and Benáková, Hana and Šimek, Jan and Dusík, Milan and Linhart, Aleš and Havránek, Štěpán},
title = {Growth differentiation factor 15 level changes in the early and late periods after radiofrequency and pulsed field catheter ablation of atrial fibrillation},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1798578}
}
EUVIMED